(Q44301754)

1 December 2017

title

Adenoviral delivery of soluble VEGF receptor 1 (sFlt-1) abrogates disease activity in murine collagen-induced arthritis (English)

1 reference

1 December 2017

1 reference

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302104

18 March 2024

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302104

18 March 2024

author name string

A. O. Afuwape

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14528319

18 March 2024

M. Feldmann

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14528319

18 March 2024

E. M. Paleolog

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14528319

18 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14528319

18 March 2024

publication date

1 November 2003

1 reference

full work available at URL

1 December 2017

https://www.nature.com/articles/3302104.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14528319

https://www.nature.com/articles/3302104.pdf

18 March 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302104

https://www.nature.com/articles/3302104

18 March 2024

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302104

18 March 2024

1 reference

1 December 2017

volume

10

1 reference

1 December 2017

issue

23

1 reference

1 December 2017

page(s)

1950-1960

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302104

1 December 2017

exact match

0 references

cites work

Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302104

Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302104

Regional suppression of tumor growth by in vivo transfer of a cDNA encoding a secreted form of the extracellular domain of the flt-1 vascular endothelial growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302104

Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302104

In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302104

Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302104

Structural studies on cartilage collagen employing limited cleavage and solubilization with pepsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302104

The angiogenesis inhibitor protease-activated kringles 1–5 reduces the severity of murine collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302104

Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302104

Suppression of collagen-induced arthritis by an angiogenesis inhibitor, AGM-1470, in combination with cyclosporin: reduction of vascular endothelial growth factor (VEGF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302104

Angiogenesis inhibition suppresses collagen arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302104

Angiostatin gene transfer as an effective treatment strategy in murine collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302104

Endostatin gene transfer inhibits joint angiogenesis and pannus formation in inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302104

Successful gene therapy via intraarticular injection of adenovirus vector containing CTLA4IgG in a murine model of type II collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302104

Gene therapy for established murine collagen-induced arthritis by local and systemic adenovirus-mediated delivery of interleukin-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302104

Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302104

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302104

Anti-adenovirus immune responses in rats are enhanced by interleukin 4 but not interleukin 10 produced by recombinant adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302104

The prevention and treatment of murine colitis using gene therapy with adenoviral vectors encoding IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302104

Adenovirus-mediated gene transfer of CTLA-4Ig fusion protein in the suppression of experimental autoimmune arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302104

Neutralization of Vascular Endothelial Growth Factor Prevents Collagen-Induced Arthritis and Ameliorates Established Disease in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302104

Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302104

7 January 2021

Treatment with soluble VEGF receptor reduces disease severity in murine collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302104

7 January 2021

Evaluation of TNF-alpha and IL-1 blockade in collagen-induced arthritis and comparison with combined anti-TNF-alpha/anti-CD4 therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302104

7 January 2021

Suppression of collagen-induced arthritis using an angiogenesis inhibitor, AGM-1470, and a microtubule stabilizer, taxol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302104

7 January 2021

Suppression of arthritis and protection from bone destruction by treatment with TNP-470/AGM-1470 in a transgenic mouse model of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302104

7 January 2021

Vascular endothelial growth factor expression and regulation of murine collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302104

7 January 2021

Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302104

7 January 2021

Viral IL-10 and soluble TNF receptor act synergistically to inhibit collagen-induced arthritis following adenovirus-mediated gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302104

7 January 2021

5

27

2339

M Nagashima

2000

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302104

18 March 2024

6

28

1482

T Pufe

2001

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302104

European Cytokine Network

18 March 2024

16

5

441

DM Butler

1994

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302104

18 March 2024

22

25

964

SJ Oliver

1998

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302104

18 March 2024

28

29

890

H Matsuno

2002

1 reference

https://api.crossref.org/works/10.1038/SJ.GT.3302104

18 March 2024

Identifiers

1 reference

1 December 2017

1 reference